121 related articles for article (PubMed ID: 2049319)
41. Bone marrow involvement in lymphoma: the importance of marrow magnetic resonance imaging.
Takagi S; Tsunoda S; Tanaka O
Leuk Lymphoma; 1998 May; 29(5-6):515-22. PubMed ID: 9643565
[TBL] [Abstract][Full Text] [Related]
42. Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy ((1)H-MRS) at the spine but not the femur.
Cohen A; Shen W; Dempster DW; Zhou H; Recker RR; Lappe JM; Kepley A; Kamanda-Kosseh M; Bucovsky M; Stein EM; Nickolas TL; Shane E
Osteoporos Int; 2015 Oct; 26(10):2471-8. PubMed ID: 25986383
[TBL] [Abstract][Full Text] [Related]
43. Clinically unsuspected Hodgkin's lymphoma diagnosed primarily from bone marrow trephine biopsy: report of six cases.
Kar R; Dutta S; Tyagi S
Indian J Pathol Microbiol; 2008; 51(2):186-9. PubMed ID: 18603677
[TBL] [Abstract][Full Text] [Related]
44. [Bone-marrow biopsy in Hodgkin's disease].
Diebold J; Temmim L; Bernadou A
Sem Hop; 1977 Jan; 53(2):103-11. PubMed ID: 189422
[TBL] [Abstract][Full Text] [Related]
45. Bone marrow biopsy in Hodgkin's disease.
Sharma S; Ahuja A; Murari M
Indian J Pathol Microbiol; 2004 Jul; 47(3):364-6. PubMed ID: 16295425
[TBL] [Abstract][Full Text] [Related]
46. [The significance of histologic assessment of the bone marrow in Hodgkin's disease].
Bartl R; Burkhardt R; Lengsfeld H; Huhn D
Klin Wochenschr; 1976 Nov; 54(22):1061-75. PubMed ID: 1003865
[TBL] [Abstract][Full Text] [Related]
47. Chronic lymphocytic leukemia: changes in bone marrow composition and distribution assessed with quantitative MRI.
Lecouvet FE; Vande Berg BC; Michaux L; Scheiff JM; Malghem J; Jamart J; Maldague BE; Michaux JL; Ferrant A
J Magn Reson Imaging; 1998; 8(3):733-9. PubMed ID: 9626894
[TBL] [Abstract][Full Text] [Related]
48. Hematopoietic reconstitution after bone marrow transplantation: assessment with MR imaging and H-1 localized spectroscopy.
Schick F; Einsele H; Kost R; Duda S; Jung WI; Lutz O; Claussen CD
J Magn Reson Imaging; 1994; 4(1):71-8. PubMed ID: 8148560
[TBL] [Abstract][Full Text] [Related]
49. Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved-field radiotherapy in transplant patients.
Kahn ST; Flowers CR; Lechowicz MJ; Hollenbach K; Johnstone PA
Cancer J; 2005; 11(5):425-31. PubMed ID: 16259874
[TBL] [Abstract][Full Text] [Related]
50. Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphoma.
Richards MA; Webb JA; Jewell SE; Amess JA; Wrigley PF; Lister TA
Br J Cancer; 1988 Apr; 57(4):412-5. PubMed ID: 3390376
[TBL] [Abstract][Full Text] [Related]
51. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases.
Brunning RD; Bloomfield CD; McKenna RW; Peterson LA
Ann Intern Med; 1975 Mar; 82(3):365-6. PubMed ID: 1172924
[TBL] [Abstract][Full Text] [Related]
52. Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.
Puccini B; Nassi L; Minoia C; Volpetti S; Ciancia R; Riccomagno PC; Di Rocco A; Mulè A; Toldo C; Sassone MC; Guariglia R; Filì C; Finolezzi E; Falorio S; Zanon S; Furlan A; Doa G; Zaja F;
Ann Hematol; 2017 Jul; 96(7):1147-1153. PubMed ID: 28451805
[TBL] [Abstract][Full Text] [Related]
53. The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas.
Gribben JG; Vaughan Hudson B; Linch DC
Hematol Oncol; 1987; 5(4):281-93. PubMed ID: 3319868
[TBL] [Abstract][Full Text] [Related]
54. Magnetic resonance imaging of the bone marrow in lymphomas and leukemias.
Tardivon AA; Vanel D; Munck JN; Bosq J
Leuk Lymphoma; 1997 Mar; 25(1-2):55-68. PubMed ID: 9130614
[TBL] [Abstract][Full Text] [Related]
55. [Autologous bone marrow transplantation for the treatment of malignant lymphoma in adults].
Da WM; Zhong JT; Huang YS
Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):640-2, 660. PubMed ID: 1582346
[TBL] [Abstract][Full Text] [Related]
56. Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.
Armitage JO; Bierman PJ; Vose JM; Anderson JR; Weisenburger DD; Kessinger A; Reed EC; Vaughan WP; Coccia PF; Purtilo DT
Am J Med; 1991 Dec; 91(6):605-11. PubMed ID: 1750430
[TBL] [Abstract][Full Text] [Related]
57. Bone marrow in malignant lymphoma.
McKenna RW; Hernandez JA
Hematol Oncol Clin North Am; 1988 Dec; 2(4):617-35. PubMed ID: 3065322
[TBL] [Abstract][Full Text] [Related]
58. Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
Phillips GL; Reece DE
Clin Haematol; 1986 Feb; 15(1):151-66. PubMed ID: 3516487
[TBL] [Abstract][Full Text] [Related]
59. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
Wheeler C; Antin JH; Churchill WH; Come SE; Smith BR; Bubley GJ; Rosenthal DS; Rappaport JM; Ault KA; Schnipper LE
J Clin Oncol; 1990 Apr; 8(4):648-56. PubMed ID: 2313334
[TBL] [Abstract][Full Text] [Related]
60. High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma.
Lazarus HM; Crilley P; Ciobanu N; Creger RJ; Fox RM; Shina DC; Bulova SI; Gucalp R; Cooper BW; Topolsky D
J Clin Oncol; 1992 Nov; 10(11):1682-9. PubMed ID: 1403051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
